Technology areas: Chemistry & Materials • Medical Devices & Mechanical Engineering
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Zeus Company LLC is currently managing 1 pending office action within the Chemistry & Materials technology area. This single action is assigned to 1 distinct examiner, reflecting a focused prosecution effort in this specific technical field. The matter is also localized within 1 distinct art unit, indicating a narrow current prosecution footprint for the company.
The busiest examiner for the portfolio is YAN LAN, who is responsible for 1 pending office action. This examiner's review will determine the immediate progress of the company's Chemistry & Materials filing. The concentration of 1 pending action under 1 examiner in 1 art unit suggests that the company's immediate interactions with the USPTO are limited to a specific point of contact.
For practitioners, this data highlights the importance of understanding YAN LAN's specific examination style. Since she handles the only pending office action within the 1 distinct art unit, her decisions will have a definitive impact on the company's current active portfolio. This focus allows for a streamlined communication process but also increases the company's reliance on a single individual's interpretation of the art unit's standards.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DOUBRAVA, JOHN A | 1 | 76.8% | +26.6% |
| LAN, YAN | 1 | 63.1% | +22.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19359289 | CATHETER LINERS, ASSEMBLIES, AND METHODS FOR PRODUCING SAME | DOUBRAVA, JOHN A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19359289 | CATHETER LINERS, ASSEMBLIES, AND METHODS FOR PRODUCING SAME | DOUBRAVA, JOHN A | — |
| 18899261 | UHMWPE PASTE EXTRUDED TUBES | LAN, YAN | — |
| Art Unit | Apps |
|---|---|
| 3783 | 1 |
| 1782 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19359289 | CATHETER LINERS, ASSEMBLIES, AND METHODS FOR PRODUCING SAME | DOUBRAVA, JOHN A | 3783 | §103§112 | Final Rejection | — | Pending | Oct 15, 2025 |
| 18899261 | UHMWPE PASTE EXTRUDED TUBES | LAN, YAN | 1782 | §103Other | Final Rejection | — | Pending | Sep 27, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialZeus Company LLC has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
John A Doubrava has the most, with 1 of Zeus Company LLC's pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
